Anti-angiogenic effects of Siegesbeckia glabrescens are mediated by suppression of the Akt and p70S6K-dependent signaling pathways

Kim,Hyeon-Ju; Ko,Hee-Young; Choi,Shin-Wook; Seo,Dong-Wan

doi:10.3892/or.2014.3630

Anti-angiogenic effects of Siegesbeckia glabrescens are mediated by suppression of the Akt and p70S6K-dependent signaling pathways

Authors:
- Hyeon-Ju Kim
- Hee-Young Ko
- Shin-Wook Choi
- Dong-Wan Seo
View Affiliations

Affiliations: College of Pharmacy, Dankook University, Cheonan 330-714, Republic of Korea, College of Biomedical Science, Kangwon National University, Chuncheon 200-701, Republic of Korea, Radiant Reasearch Institute, Radiant Inc., Chuncheon 200-883, Republic of Korea
Published online on: November 26, 2014 https://doi.org/10.3892/or.2014.3630
Pages: 699-704

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Siegesbeckia glabrescens (SG) Makino (Compositae) has been used as a traditional medicine for the treatment of allergic and inflammatory diseases. In the present study, we report the effects and molecular mechanism of an ethanolic extract of SG on cell proliferation, migration and tube formation in vascular endothelial growth factor-A (VEGF-A)-treated human umbilical vein endothelial cells. SG treatment inhibited VEGF-A-stimulated endothelial cell proliferation through downregulation of cyclin D and upregulation of cyclin-dependent kinase inhibitors such as p27Kip1 and p21WAF1/Cip1. In addition, SG inhibited VEGF‑A-stimulated endothelial cell migration and tube formation. These anti-angiogenic activities of SG were mediated by inactivation of the Akt- and p70S6K-dependent signaling pathways. Collectively, our findings demonstrate the pharmacological roles and molecular mechanism of SG in regulating angiogenic responses and support further evaluation and development of SG as a potential therapeutic agent for the treatment and prevention of angiogenesis-related diseases including cancer.

View Figures

View References

1	Folkman J: Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 6:273–286. 2007. View Article : Google Scholar : PubMed/NCBI
2	Carmeliet P and Jain RK: Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 10:417–427. 2011. View Article : Google Scholar : PubMed/NCBI
3	Brown DM and Regillo CD: Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol. 144:627–637. 2007. View Article : Google Scholar : PubMed/NCBI
4	Cook KM and Figg WD: Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin. 60:222–243. 2010. View Article : Google Scholar : PubMed/NCBI
5	Ng EW, Shima DT, Calias P, Cunningham ET Jr, Guyer DR and Adamis AP: Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 5:123–132. 2006. View Article : Google Scholar : PubMed/NCBI
6	Jain RK, Duda DG, Clark JW and Loeffler JS: Lessons from phase III clinical trials on anti-VEGF therapy for cancer. Nat Clin Prac Oncol. 3:24–40. 2006. View Article : Google Scholar
7	Kang BK, Lee EH and Kim HM: Inhibitory effects of Korean folk medicine ‘Hi-Chum’ on histamine release from mast cells in vivo and in vitro. J Ethnopharmacol. 57:73–79. 1997. View Article : Google Scholar : PubMed/NCBI
8	Kim JY, Lim HJ and Ryu JH: In vitro anti-inflammatory activity of 3-O-methyl-flavones isolated from Siegesbeckia glabrescens. Bioorg Med Chem Lett. 18:1511–1514. 2008. View Article : Google Scholar : PubMed/NCBI
9	Kim HM, Lee JH, Won JH, et al: Inhibitory effect on immunoglobulin E production in vivo and in vitro by Siegesbeckia glabrescens. Phytother Res. 15:572–576. 2001. View Article : Google Scholar : PubMed/NCBI
10	Jun SY, Choi YH and Shin HM: Siegesbeckia glabrescens induces apoptosis with different pathways in human MCF-7 and MDA-MB-231 breast carcinoma cells. Oncol Rep. 15:1461–1467. 2006.PubMed/NCBI
11	Cho YR, Choi S and Seo DW: The in vitro antitumor activity of Siegesbeckia glabrescens against ovarian cancer through suppression of receptor tyrosine kinase expression and the signaling pathways. Oncol Rep. 30:221–226. 2013.PubMed/NCBI
12	Lee HN, Joo JH, Oh JS, Choi SW and Seo DW: Regulatory effects of Siegesbeckia glabrescens on non-small cell lung cancer cell proliferation and invasion. Am J Chin Med. 42:453–463. 2014. View Article : Google Scholar : PubMed/NCBI
13	Hwang JH and Kim JD: Inhibitory effects of Siegesbeckiae herba extract on angiogenesis and adipogenesis. Biotechnol Bioprocess Eng. 16:144–152. 2011. View Article : Google Scholar
14	Kim HJ, Cho YR, Kim SH and Seo DW: TIMP-2-derived 18-mer peptide inhibits endothelial cell proliferation and migration through cAMP/PKA-dependent mechanism. Cancer Lett. 343:210–216. 2014. View Article : Google Scholar
15	Lee HN, Kim JK, Kim JH, et al: A mechanistic study on the anti-cancer activity of ethyl caffeate in human ovarian cancer SKOV-3 cells. Chem Biol Interact. 219:151–158. 2014. View Article : Google Scholar : PubMed/NCBI
16	Seo DW, Kim SH, Eom SH, et al: TIMP-2 disrupts FGF-2-induced downstream signaling pathways. Microvasc Res. 76:145–151. 2008. View Article : Google Scholar : PubMed/NCBI
17	Seo DW, Li H, Qu CK, et al: Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem. 281:3711–3721. 2006. View Article : Google Scholar :
18	Kim SH, Cho YR, Kim MD, Kim HJ, Choi SW and Seo DW: Inhibitory effects of sepiapterin on vascular endothelial growth factor-A-induced proliferation and adhesion in human umbilical vein endothelial cells. Arch Pharm Res. 34:1571–1577. 2011. View Article : Google Scholar : PubMed/NCBI
19	Yoon HJ, Cho YR, Joo JH and Seo DW: Knockdown of integrin α3β1 expression induces proliferation and migration of non-small cell lung cancer cells. Oncol Rep. 29:662–668. 2013.
20	Bourboulia D and Stetler-Stevenson WG: Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 20:161–168. 2010. View Article : Google Scholar : PubMed/NCBI
21	Christofori G: New signals from the invasive front. Nature. 441:444–450. 2006. View Article : Google Scholar : PubMed/NCBI
22	Lemmon MA and Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010. View Article : Google Scholar : PubMed/NCBI
23	Li H, Kim JY, Hyeon J, Lee HJ and Ryu JH: In vitro antiinflammatory activity of a new sesquiterpene lactone isolated from Siegesbeckia glabrescens. Phytother Res. 25:1323–1327. 2011.PubMed/NCBI
24	Olsson AK, Dimberg A, Kreuger J and Claesson-Welsh L: VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol. 7:359–371. 2006. View Article : Google Scholar : PubMed/NCBI
25	Ellis LM and Hicklin DJ: VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer. 8:579–591. 2008. View Article : Google Scholar : PubMed/NCBI
26	Kim SH, Cho YR, Kim HJ, et al: Antagonism of VEGF-A-induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway. Blood. 120:4892–4902. 2012. View Article : Google Scholar : PubMed/NCBI
27	Kessenbrock K, Plaks V and Werb Z: Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 141:52–67. 2010. View Article : Google Scholar : PubMed/NCBI
28	Stetler-Stevenson WG: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest. 103:1237–1241. 1999. View Article : Google Scholar : PubMed/NCBI
29	Stetler-Stevenson WG: Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities. Sci Signal. 1:re62008.PubMed/NCBI
30	Brew K and Nagase H: The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta. 1803:55–71. 2010. View Article : Google Scholar : PubMed/NCBI
31	Seo DW, Li H, Guedez L, et al: TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 114:171–180. 2003. View Article : Google Scholar : PubMed/NCBI